Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00949130 · ClinicalTrials.gov registry record · Phase 2
Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
A Phase 2 study of Acute Bacterial Skin and Skin Structure Infections, sponsored by Novexel.
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
- 15
- Study locations
NCT00949130: Completed Phase 2 study of Acute Bacterial Skin and Skin Structure Infections, sponsored by Novexel.
NCT00949130 is a Phase 2 study of Acute Bacterial Skin and Skin Structure Infections that has completed, run by Novexel. The registered enrollment target is 180 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher). The trial reports 15 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00949130, a Phase 2 study of Acute Bacterial Skin and Skin Structure Infections, has completed, sponsored by Novexel.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
- 15
- Study locations
Study Summary
The objective of this study is to evaluate the efficacy and safety of oral NXL103 vs. established treatment of acute bacterial infection in adults.
Conditions Studied
Interventions
- DRUG NXL103
- DRUG Linezolid
Study Locations (15)
California
- Sharp Chula Vista Research Office - Chula Vista
- Fountain Valley Regional Hospital and Medical Center - Fountain Valley
- Sharp Grossmont Research Office - La Mesa
- Tri-City Oceanside Office - Oceanside
Other
- Roosevelt Hospital - Guatemala City
- UNICAR - Guatemala City
- Military Health Center - Guatemala City
- Private Hospital - Quetzaltenango
Georgia
- Southeast Regional Research Group - Columbus
- Southeast Regional Research Group - Savannah
Minnesota
- Hennepin County Medical Center - Minneapolis
- Infectious Diseaes MPLS-LTD - Minneapolis
Idaho
- Idaho Falls Infectious Diseases - Idaho Falls
Montana
- Mercury Street Medical Group - Butte
Pennsylvania
- RPS Infectious Diseases - West Reading
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-03 |
| Phase | Phase 2 |
What the finished NCT00949130 record still lists
NCT00949130 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (35% higher).
The record links to 1 condition, with Acute Bacterial Skin and Skin Structure Infections appearing as the primary indexed condition, and to 2 interventions - of which NXL103 is the first listed.
NCT00949130 lists 15 locations in 7 states (California, Other, Georgia).
Frequently Asked Questions
What is clinical trial NCT00949130 about?
NCT00949130 is a clinical study titled "Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)". The objective of this study is to evaluate the efficacy and safety of oral NXL103 vs. established treatment of acute bacterial infection in adults.
What is the current status of trial NCT00949130?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2009-11. Estimated completion is 2010-03.
What conditions does trial NCT00949130 study?
This clinical trial studies the following conditions: Acute Bacterial Skin and Skin Structure Infections.
What interventions are being tested in trial NCT00949130?
The interventions under investigation include: NXL103 (DRUG), Linezolid (DRUG).
Who is sponsoring clinical trial NCT00949130?
This trial is sponsored by Novexel, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00949130 being conducted?
This trial has 15 study locations across California, Georgia, Idaho, Minnesota, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Bacterial Skin and Skin Structure Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00949130's enrollment target sits among peer trials
180 365th of 2000 higher than 1,610 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia